tiprankstipranks
Eledon Pharmaceuticals (DE:2TK)
FRANKFURT:2TK
Germany Market
2TK
Eledon Pharmaceuticals
RESEARCH TOOLSreports

Eledon Pharmaceuticals (2TK) Income Statement

1 Followers

Eledon Pharmaceuticals Income Statement

Last quarter (Q2 2026), Eledon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Eledon Pharmaceuticals's net income was $-31.63M. See Eledon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 83.25M$ 70.58M$ 43.00M$ 88.43M$ 36.87M
Depreciation and Amortization
$ 313.00K$ 359.00K$ 374.00K$ 373.00K$ 195.00K
EBITDA
$ -45.27M$ -35.39M$ -116.16M$ -39.41M$ -36.66M
Operating Income
$ -83.25M$ -70.58M$ -43.00M$ -88.43M$ -36.87M
Other Income/Expenses
$ 37.67M$ 34.82M$ -73.54M$ 462.00K$ 7.00K
Pretax Income
$ -45.58M$ -35.75M$ -116.54M$ -87.97M$ -36.86M
Net Income
$ -45.62M$ -36.18M$ -116.54M$ -87.97M$ -34.51M
Per Share Metrics
Basic EPS
$ -0.56$ -0.75$ -4.73$ -6.16$ -2.33
Diluted EPS
$ -0.56$ -0.75$ -4.73$ -6.16$ -2.33
Weighted Average Shares Outstanding
 81.84M 48.54M 24.62M 14.29M 14.82M
Weighted Average Shares Outstanding (Diluted)
 81.84M 48.54M 24.62M 14.29M 14.82M
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History